Antipsychotic agents in anxiety disorders: An umbrella review.
Amir GarakaniFrank D BuonoMona SalehiMelissa C FunaroAnna KlimowiczHarshit SharmaClara G F FariaKaitlyn LarkinRafael Christophe FreirePublished in: Acta psychiatrica Scandinavica (2024)
This umbrella review indicates a lack of high-quality studies of antipsychotics in anxiety disorders outside of the use of quetiapine in GAD. Although potentially effective for anxiety disorders, FGAs and SGAs may have risks and side effects that outweigh their efficacy, although there were limited data. Further long-term and larger-scale studies of antipsychotics in anxiety disorders are needed.